Vigilant Capital Management’s Medpace MEDP Stock Holding History

Vigilant Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-500	Closed	-$42K	–	393
2019 Q4	$42K	Buy	+500	New	+$38.7K	﹤0.01%	318

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vigilant Capital Management's MEDP Position: Q1 2020 in Review

Vigilant Capital Management sold out of Medpace (MEDP) in Q1 2020, closing a stake of 500 shares — an estimated $42K sold.

Vigilant Capital Management first reported a position in MEDP in Q4 2019 and held it in 1 quarter. The position peaked at $42K in Q4 2019. 269 funds tracked by Wall St. Rank hold MEDP as of Q1 2020.

Vigilant Capital Management reported no remaining Medpace position as of Q1 2020 after selling out during the quarter.
Vigilant Capital Management sold 500 Medpace shares in Q1 2020, an estimated $42K.
Vigilant Capital Management first reported a position in Medpace in Q4 2019 and held it in 1 quarter.
Vigilant Capital Management's Medpace position peaked at $42K in Q4 2019.
269 funds tracked by Wall St. Rank held Medpace as of Q1 2020.

Based on Vigilant Capital Management's 13F filing for Q1 2020, filed 17 Apr 2020.